BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30317893)

  • 21. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.
    Slyker JA; Casper C; Tapia K; Richardson B; Bunts L; Huang ML; Maleche-Obimbo E; Nduati R; John-Stewart G
    J Infect Dis; 2013 Jun; 207(12):1798-806. PubMed ID: 23493724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
    Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
    Stevens SJ; Pronk I; Middeldorp JM
    J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection.
    Friis AM; Akerlund B; Gyllensten K; Aleman A; Bratt G; Sandström E; Ernberg I
    Vaccine; 2012 Sep; 30(42):6093-8. PubMed ID: 22863659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection.
    Wang J; Ozzard A; Nathan M; Atkins M; Nelson M; Gazzard B; Bower M
    HIV Med; 2007 Jul; 8(5):306-11. PubMed ID: 17561877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
    Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
    Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
    Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
    BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma.
    Ul-Haq I; Dalla Pria A; Suardi E; Pinato DJ; Froeling F; Forni J; Randell P; Bower M
    Med Oncol; 2018 Mar; 35(4):53. PubMed ID: 29536181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
    Correa RM; Fellner MD; Durand K; Redini L; Alonio V; Yampolsky C; Colobraro A; Sevlever G; Teyssié A; Benetucci J; Picconi MA
    J Med Virol; 2007 Apr; 79(4):401-7. PubMed ID: 17311329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
    van Baarle D; Hovenkamp E; Callan MF; Wolthers KC; Kostense S; Tan LC; Niesters HG; Osterhaus AD; McMichael AJ; van Oers MH; Miedema F
    Blood; 2001 Jul; 98(1):146-55. PubMed ID: 11418474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin's lymphoma.
    Fleisch F; Reinhart WH; Brand B; Berger C
    Swiss Med Wkly; 2005 Apr; 135(17-18):263-5. PubMed ID: 15965829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
    Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
    J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of blood Epstein-Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.
    Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Filippova A; Prevot S; Costagliola D; Morand P; Besson C
    AIDS; 2021 May; 35(6):861-868. PubMed ID: 33749224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
    Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
    BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Close relationship between immunoglobulin secreting-cells and Epstein-Barr virus reservoir in patients infected with HIV.
    Ouedraogo DE; Tuaillon E; Rubbo PA; Bollore K; Foulongne V; Reynes J; Vendrell JP
    J Med Virol; 2014 Jan; 86(1):30-7. PubMed ID: 24114930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma.
    Kim HS; Kim KH; Kim KH; Chang MH; Ji SH; Lim DH; Kim K; Kim SJ; Ko Y; Ki CS; Jo SJ; Lee JW; Kim WS
    Leuk Lymphoma; 2009 May; 50(5):757-63. PubMed ID: 19330658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.